Y
Yue Zhong Wu
Researcher at Ohio State University
Publications - 22
Citations - 5096
Yue Zhong Wu is an academic researcher from Ohio State University. The author has contributed to research in topics: DNA methylation & Restriction landmark genomic scanning. The author has an hindex of 19, co-authored 22 publications receiving 4774 citations. Previous affiliations of Yue Zhong Wu include Wake Forest University.
Papers
More filters
Journal ArticleDOI
Epigenetic differences arise during the lifetime of monozygotic twins
Mario F. Fraga,Esteban Ballestar,Maria F. Paz,Santiago Ropero,Fernando Setien,Maria Luisa Ballestar,Damia Heine-Suñer,Juan C. Cigudosa,Miguel Urioste,Javier Benitez,Manuel Boix-Chornet,Abel Sánchez-Aguilera,Charlotte Ling,Emma Carlsson,Pernille Poulsen,Allan Vaag,Zarko Stephan,Tim D. Spector,Yue Zhong Wu,Christoph Plass,Manel Esteller +20 more
TL;DR: Older monozygous twins exhibited remarkable differences in their overall content and genomic distribution of 5-methylcytosine DNA and histone acetylation, affecting their gene-expression portrait, indicating how an appreciation of epigenetics is missing from the understanding of how different phenotypes can be originated from the same genotype.
Journal ArticleDOI
Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
Shujun Liu,Lai-Chu Wu,Jiuxia Pang,Ramasamy Santhanam,Sebastian Schwind,Yue Zhong Wu,Christopher Hickey,Jianhua Yu,Heiko Becker,Kati Maharry,Michael D. Radmacher,Chenglong Li,Susan P. Whitman,Anjali Mishra,Nicole Stauffer,Anna M. Eiring,Roger Briesewitz,Robert A. Baiocchi,Kenneth K. Chan,Peter Paschka,Michael A. Caligiuri,John C. Byrd,Carlo M. Croce,Clara D. Bloomfield,Danilo Perrotti,Ramiro Garzon,Guido Marcucci +26 more
TL;DR: These results provide evidence that the mechanisms of Sp1/NFkappaB/HDAC/miR-29b-dependent KIT overexpression contribute to leukemia growth and can be successfully targeted by pharmacological disruption of the Sp1 /NFkappB/ HDAC complex or synthetic miR- 29b treatment in KIT-driven AML.
Journal ArticleDOI
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
Li Yu,Chunhui Liu,Jeff Vandeusen,Brian Becknell,Zunyan Dai,Yue Zhong Wu,Aparna Raval,Te Hui Liu,Wei Ding,Charlene Mao,Shujun Liu,Laura T. Smith,Stephen Lee,Laura Z. Rassenti,Guido Marcucci,John C. Byrd,Michael A. Caligiuri,Christoph Plass +17 more
TL;DR: This work developed a mouse model of T/natural killer acute lymphoblastic leukemia that is always preceded by polyclonal lymphocyte expansion to determine how aberrant promoter DNA methylation and consequent gene silencing might be contributing to leukemic transformation.
Journal ArticleDOI
Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome
Cinzia Allegrucci,Yue Zhong Wu,Alexandra Thurston,Chris Denning,Helen Priddle,Christine L. Mummery,Dorien Ward-van Oostwaard,Peter W. Andrews,Miodrag Stojkovic,Nigel Smith,Tony Parkin,Mark Edmondson Jones,Graham Warren,Li Yu,Romulo M. Brena,Christoph Plass,Lorraine E. Young +16 more
TL;DR: Current methods of hESC propagation can rapidly programme stable and unpredictable epigenetic changes in the stem cell genome, which highlights the need for novel screening strategies and standardization of procedures for the derivation and culture of h ESC lines that minimize culture-induced instability.
Journal ArticleDOI
A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes
Zunyan Dai,Wei-Guo Zhu,Carl Morrison,Romulo M. Brena,Dominic J. Smiraglia,Aparna Raval,Yue Zhong Wu,Laura J. Rush,Patrick Ross,Julian R. Molina,Gregory A. Otterson,Christoph Plass +11 more
TL;DR: One novel amplicon is identified on chromosome 11q22, in addition to previously reported amplicons that include oncogenes MYCC, MYCL1 and previously identified amplification of chromosomal regions 6q21 and 3q26-27, which has been reported in other types of cancer.